Start by naming the pack. Compatibility work evaluates a specific formula in a specific container system. Specify the actual material, dimensions and closure rather than only naming the format family. Two twist-off units can differ in polymer, headspace, opening geometry and carton. Until those items are written down, an observation cannot be tied to a pack you can reorder.
Filling route sits beside that file. BFS manufacturing and preformed aseptic filling change how the container is made and closed. They do not answer whether this formula holds in this version under the storage and use conditions you intend to support.
Name the pack version before you test
Record the packaging specification before testing. Record the material, the opening method, the intended fill, the closure or moulded head, and the secondary pack that will ship with the unit. A BFS strip and a preformed vial are two versions. The same BFS geometry in two polymers is two versions. A drawing, a mould or component code, or a retained sample from a named trial is enough to start. A mood-board photograph is not.
What belongs in a compatibility review brief
Define the study before comparing results
- Identify the samplesRecord the formula, material, closure and packaging version.
- Agree the conditionsState intended storage, transport and opening conditions.
- Plan the reviewName the observations, acceptance criteria and change triggers.
The brief should let a later reader tell which formula and which pack produced the observations. Testing "the ampoule" against an unnamed serum is not a brief.
- Formula identity and status. Lab batch or intended composition, known solvents, oils, fragrance and actives, and whether the formula is still moving.
- Packaging version. Material, opening, fill target, closure or moulded head, and secondary pack.
- Filling route under discussion. BFS, preformed aseptic filling, or both still open.
- Intended storage. Retail shelf, clinic cupboard, travel, or a cold-chain claim if that is actually planned, named as a condition, not copied from another SKU.
- Intended use. One opening, whether residue is left in the unit, and whether anyone is expected to recap it.
- Observations the study should answer. Appearance, odour, leakage, dispense, weight change, and any other question needed before a larger run.
- Owner and trigger. Who writes the protocol, who accepts the version, and what change reopens the file.
A cosmetics stability guideline leaves that protocol to be specified and justified for the product. It does not publish one set of conditions for every formula and pack. See the ISO/TR 18811 abstract.
Formula and pack interactions to put on the list
The sealed single-dose unit is already a reason to look at packaging; that rationale lives on why single-dose packaging matters for skincare stability. This page is the next step: which contact and handling questions belong on the named version. Write them as questions, not as assumed chemistry.
- Does the formula contact a polymer, a stopper, a liner or a moulded head, and has that contact been named?
- Is the pack clear, tinted or cartoned in a way that changes light exposure in storage?
- Is headspace a stated concern for this composition, and does the fill method leave it consistent?
- Can the intended dose leave the unit through the designed opening without forcing the seal?
- Does the opening or closure hold during packing, shipping and handling?
- Does the carton, tray or sleeve add abrasion, compression or a light block the primary pack does not provide?
Those questions change with the version. A twist-off BFS unit and a stoppered vial can raise different contact and dispense items even when the fill volume looks similar.
Storage and use conditions belong in the same file
A compatibility file that names the pack and forgets how the product will live is incomplete. Storage, transport and the way the unit is opened are part of the same design. Independent laboratories describe both real-time and accelerated programmes, and they treat the environment the product will meet as part of that design. See SGS on stability testing.
Write the conditions you actually intend to support. A clinic-only serum in a cupboard is a different brief from a travel-retail unit that may sit in a bag. A unit opened once is a different use condition from a jar recapped for weeks. If the market, channel or in-use story is still unnamed, say so. An open condition is visible; a silent assumption is not.
Change control after the first review
The first compatibility file covers the formula and pack version that went into it. Reopen the brief when any of the following moves:
- formula composition, including a fragrance, solvent or active change that looks small on a marketing deck
- polymer, stopper, liner or moulded-head material
- opening method or fill target
- secondary pack that travels with the unit
- intended storage, channel or use story used to justify the protocol
The useful question in a manufacturing review is which file still matches the unit you want to run. The compatibility brief is the input that tells later process and pack-integrity checks which version they are looking at.
Hypothetical: two pack versions, one formula change
The following scenario is hypothetical. It is a decision pattern, not a client file.
A brand has a water-based antioxidant serum and two candidate packs: a twist-off BFS unit in a named polymer, and a preformed vial with a specified stopper. The brief records the same formula batch against both versions, names room-temperature retail storage with no refrigeration claim, and describes use as one opening with no recap. Observations listed: appearance, odour, leakage, and whether the dose dispenses through the designed opening.
During sampling, fragrance is removed from the formula. The pack drawings do not change. The team still reopens the brief, because the formula identity in the file is no longer the formula they intend to fill. They keep both pack versions on the list until each version has a matching formula identity.
Buyer decision checklist
Use this list before a project review. If several answers are still blank, the compatibility conversation is not finished.
- Can you point to one named pack version, material, opening, fill, secondary pack, or are you still testing a category?
- Is the formula identity in the brief the formula you still intend to fill?
- Are storage and use written as conditions for this product, or borrowed from another SKU?
- Which observations will count as answers, and who accepts them?
- What change to formula, pack or channel would reopen the file?
- Is the filling route named, still open, or being asked to stand in for a missing pack version?
When the version, the conditions and the change trigger are written down, take the brief into a manufacturing review. Facilities & Quality is the page for how line assignment and evidence handling are discussed together.